RWM
INDV icon

Ritholtz Wealth Management’s Indivior Pharmaceuticals INDV Stock Holding History

Ritholtz Wealth Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.98M Buy
121,304
+6,526
+6% +$237K 0.07% 180
2026
Q1 		$3.5M Sell
114,778
-1,483
-1% -$49K 0.06% 238
2025
Q4 		$4.17M Buy
116,261
+23,416
+25% +$715K 0.08% 179
2025
Q3 		$2.24M Buy
+92,845
New +$1.94M 0.04% 302

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ritholtz Wealth Management's INDV Position: Q2 2026 in Review

Ritholtz Wealth Management increased its Indivior Pharmaceuticals (INDV) stake by 5.7% in Q2 2026, buying an estimated $237K and bringing the position to 121,304 shares worth $4.98M. The position accounts for 0.07% of the portfolio, ranked #180.

Ritholtz Wealth Management first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Ritholtz Wealth Management held 121,304 shares of Indivior Pharmaceuticals worth $4.98M as of Q2 2026.
  • Ritholtz Wealth Management bought 6,526 Indivior Pharmaceuticals shares in Q2 2026, an estimated $237K.
  • Indivior Pharmaceuticals made up 0.07% of Ritholtz Wealth Management's portfolio in Q2 2026, its #180 holding.
  • Ritholtz Wealth Management first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.